Skip to main content
Spirox to be acquired by Entellus Medical in $81M deal

Entellus Medical has agreed to pay about 3.4 million in shares of its common stock, valued at approximately $56 million, and $25 million in cash for Redwood City, Calif.-based Spirox, maker of the Latera Absorbable Nasal Implant. The acquisition, which includes four years of additional contingent payments depending on revenue growth, is expected to expand Entellus' portfolio of products designed for sinusitis treatment.

Full Story: